Cite
HARVARD Citation
Mohammed, S. et al. (n.d.). The BET protein inhibitor apabetalone (RVX-208) restores angiogenic response in type 1 and type 2 diabetes by transcriptional regulation of thrombospondin-1. European heart journal. p. . [Online].